Glial papillary tumour of the spinal cord with SMARCB1/INI1-loss and favourable long-term outcome

Neuropathol Appl Neurobiol. 2018 Feb;44(2):229-232. doi: 10.1111/nan.12395.

M Hasselblatt¹, A D Kurniawan², S Rozsnoki¹, P D Johann^{3

4

5}, S Bens⁶, F Oyen⁷, R Schneppenheim⁷, R Siebert⁶, D Capper^{4

8

9}, M Kool^{3

4}, C Schul², W Paulus¹

¹ Institute of Neuropathology, University Hospital Münster, Münster, Germany.
² Department of Neurosurgery, Klinikum Kempten, Kempten, Germany.
³ Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴ German Cancer Consortium (DKTK), Core Center Heidelberg, Heidelberg, Germany.
⁵ Department of Paediatric Oncology and Haematology, University Hospital Heidelberg, Heidelberg, Germany.
⁶ Institute of Human Genetics, University Ulm and University of Ulm Medical Center, Ulm, Germany.
⁷ Department of Paediatric Haematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
⁸ Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
⁹ Clinical Cooperation Unit Neuropathology, German Research Center (DKFZ), Heidelberg, Germany.

No abstract available

Publication types